Compound details
Aloesone
| Compound ID | CDAMM00352 |
|---|---|
| Common name | Aloesone | IUPAC name | 7-hydroxy-5-methyl-2-(2-oxopropyl)chromen-4-one |
| Molecular formula | C13H12O4 |
| Retention time | 46.984 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 233.082 | Theoretical mz | 233.081 |
| Error | 4.56 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.74 |
| Inchi key | JHELBXAAAYUKCT-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C1C=C(OC2=CC(O)=CC(=C12)C)CC(=O)C |
| Superclass | Organoheterocyclic compounds |
| Class | Benzopyrans |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P51679 | CCR4 | C-C chemokine receptor type 4 | T06955 | SEA |
| Q9HC98 | NEK6 | Serine/threonine-protein kinase NEK6 | T78992 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SEA |
| Q99417 | MYCBP | MYCBP messenger RNA | T37298 | SEA |
| P16220 | CREB1 | Cyclic AMP-responsive element-binding protein | T92098 | SEA |
| Q15717 | ELAVL1 | ELAV-like protein 1 | T78349 | SEA |
| Q9UK17 | KCND3 | Voltage-gated potassium channel Kv4.3 | T74500 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T06955 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P51679 | CCR4 |
| T06955 | DI0379 | Sezary syndrome | [ICD-11: 2B02] | P51679 | CCR4 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T37298 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q99417 | MYCBP |
| T74500 | DI0004 | Acidosis | [ICD-11: 5C73] | Q9UK17 | KCND3 |